Daré Bioscience, Inc. (DARE)

Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.62	24.71	15.7	10.48	34.67	51.67
Cash & Short-Term Investments	12.62	24.71	15.7	10.48	34.67	51.67
Cash Growth	150.60%	57.42%	49.85%	-69.78%	-32.91%	1006.64%
Other Receivables	0.46	0.57	0.23	0.95	1.7	1.15
Receivables	0.46	0.57	0.23	0.95	1.7	1.15
Prepaid Expenses	2.78	1.39	2.52	6.12	6.67	2.48
Other Current Assets	0.84	0.39	-	-	-	-
Total Current Assets	16.69	27.06	18.45	17.54	43.04	55.3
Property, Plant & Equipment	3.13	4.4	2.54	1.98	0.52	0.24
Long-Term Deferred Charges	-	-	-	-	-	0.14
Other Long-Term Assets	2.55	1.01	1.11	1.76	0.26	0.13
Total Assets	22.37	32.47	22.1	21.28	43.83	55.81

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.76	1.2	1.46	3.39	2.03	2.1
Accrued Expenses	0.45	0.73	3.04	2.89	10.89	3.14
Current Portion of Long-Term Debt	-	0.01	0	-	-	-
Current Portion of Leases	0.74	2.1	0.55	0.47	0.4	0.27
Current Unearned Revenue	14.95	19.65	16.56	13.74	18.3	10.54
Other Current Liabilities	0.01	-	-	-	-	-
Total Current Liabilities	16.92	23.69	21.61	20.48	31.62	16.05
Long-Term Debt	-	5.39	4.75	-	-	-
Long-Term Leases	0.27	0.56	0.75	0.94	0.09	-
Long-Term Unearned Revenue	-	-	1	1	1	1
Other Long-Term Liabilities	5.73	-	-	3.91	-	-
Total Liabilities	22.93	29.63	28.11	26.33	32.71	17.05

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	194.48	191.95	169.71	166.55	152.53	149.03
Retained Earnings	-194.67	-188.69	-175.29	-171.24	-141.07	-110.13
Comprehensive Income & Other	-0.37	-0.42	-0.43	-0.36	-0.35	-0.15
Shareholders' Equity	-0.56	2.84	-6.01	-5.05	11.11	38.75
Total Liabilities & Equity	22.37	32.47	22.1	21.28	43.83	55.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.02	8.05	6.05	1.4	0.49	0.27
Net Cash (Debt)	11.6	16.66	9.65	9.07	34.18	51.4
Net Cash Growth	479.33%	72.69%	6.33%	-73.46%	-33.51%	1213.79%
Net Cash Per Share	0.82	1.49	1.14	1.25	4.85	10.09
Filing Date Shares Outstanding	15.29	14.56	8.85	8.38	7.18	7
Total Common Shares Outstanding	15.17	14.5	8.7	8.33	7.07	7
Working Capital	-0.24	3.38	-3.17	-2.94	11.41	39.24
Book Value Per Share	-0.04	0.20	-0.69	-0.61	1.57	5.54
Tangible Book Value	-0.56	2.84	-6.01	-5.05	11.11	38.75
Tangible Book Value Per Share	-0.04	0.20	-0.69	-0.61	1.57	5.54
Machinery	-	1.86	0.24	0.16	-	-
Construction In Progress	-	-	1.23	0.6	-	-
Leasehold Improvements	-	0.04	0.04	0.04	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error